89bio Inc [NASDAQ: ETNB] slipped around 0.0 points on Monday, while shares priced at $14.87 at the close of the session, down 0.00%.
89bio Inc stock is now 78.94% up from its year-to-date (YTD) trading value. ETNB Stock saw the intraday high of $14.91 and lowest of $14.835 per share. The company’s 52-week high price is 15.06, which means current price is +257.45% above from all time high which was touched on 09/18/25.
Compared to the average trading volume of 3.19M shares, ETNB reached a trading volume of 14372664 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about 89bio Inc [ETNB]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ETNB shares is $31.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ETNB stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for 89bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 04, 2025. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on March 14, 2025, representing the official price target for 89bio Inc stock. Previously, the target price had yet another raise to $25, while Citigroup analysts kept a Buy rating on ETNB stock.
The Price to Book ratio for the last quarter was 4.23, with the Price to Cash per share for the same quarter was set at 3.78.
How has ETNB stock performed recently?
89bio Inc [ETNB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 85.41. With this latest performance, ETNB shares gained by 61.81% in over the last four-week period, additionally plugging by 74.53% over the last 6 months – not to mention a rise of 90.15% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ETNB stock in for the last two-week period is set at 81.38, with the RSI for the last a single of trading hit 0.95, and the three-weeks RSI is set at 0.73 for 89bio Inc [ETNB]. The present Moving Average for the last 50 days of trading for this stock 9.63, while it was recorded at 12.15 for the last single week of trading, and 8.80 for the last 200 days.
89bio Inc (ETNB) Capital Structure & Debt Analysis
According to recent financial data for 89bio Inc. ( ETNB), the Return on Equity (ROE) stands at -86.86%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -75.94%, reflecting the company’s efficiency in generating profits from its assets. Additionally, 89bio Inc’s Return on Invested Capital (ROIC) is -80.60%, showcasing its effectiveness in deploying capital for earnings.
89bio Inc (ETNB) Efficiency & Liquidity Metrics
Based on 89bio Inc’s (ETNB) latest financial statements, the Debt-to-Equity Ratio is 0.07%, indicating its reliance on debt financing relative to shareholder equity.
89bio Inc (ETNB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, 89bio Inc. (ETNB) effectively leverages its workforce, generating an average of -$4840967.74 per employee. The company’s liquidity position is robust, with a Current Ratio of 15.19% and a Quick Ratio of 15.19%, indicating strong ability to cover short-term liabilities.
Earnings analysis for 89bio Inc [ETNB]
With the latest financial reports released by the company, 89bio Inc posted -1.39/share EPS, while the average EPS was predicted by analysts to be reported at -0.64/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.75. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ETNB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for 89bio Inc go to 13.66%.
Insider trade positions for 89bio Inc [ETNB]
There are presently around $111.77%, or 112.38%% of ETNB stock, in the hands of institutional investors. The top three institutional holders of ETNB stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 14.18 million shares, which is approximately 14.1994%. JANUS HENDERSON GROUP PLC, holding 13.28 million shares of the stock with an approximate value of $$106.32 million in ETNB stocks shares; and JANUS HENDERSON GROUP PLC, currently with $$64.34 million in ETNB stock with ownership which is approximately 8.0454%.
